RADIOMETER MEDICAL ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  2.3% 2.3% 2.3% 2.3% 2.3%  
Bankruptcy risk  0.5% 0.5% 0.5% 0.6% 0.5%  
Credit score (0-100)  99 99 99 98 98  
Credit rating  AA AAA AAA AA AA  
Credit limit (mDKK)  689.1 788.1 616.6 456.0 532.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  4,344 4,687 5,047 5,506 5,588  
Gross profit  2,054 2,291 2,367 2,477 2,624  
EBITDA  1,158 1,307 1,273 1,293 1,468  
EBIT  803 958 904 494 1,144  
Pre-tax profit (PTP)  903.6 1,014.0 956.6 563.2 1,280.1  
Net earnings  715.8 824.5 783.4 477.9 1,018.8  
Pre-tax profit without non-rec. items  904 1,014 957 563 1,280  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  147 150 163 130 116  
Shareholders equity total  6,262 7,085 5,369 3,947 4,368  
Interest-bearing liabilities  189 178 628 447 632  
Balance sheet total (assets)  7,707 8,546 7,116 5,419 5,838  

Net Debt  185 162 619 403 606  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  4,344 4,687 5,047 5,506 5,588  
Net sales growth  14.5% 7.9% 7.7% 9.1% 1.5%  
Gross profit  2,054 2,291 2,367 2,477 2,624  
Gross profit growth  13.9% 11.5% 3.3% 4.6% 5.9%  
Employees  1,101 1,134 1,164 1,188 1,142  
Employee growth %  3.1% 3.0% 2.6% 2.1% -3.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,707 8,546 7,116 5,419 5,838  
Balance sheet change%  -49.4% 10.9% -16.7% -23.8% 7.7%  
Added value  1,157.6 1,307.1 1,272.9 863.1 1,468.0  
Added value %  26.6% 27.9% 25.2% 15.7% 26.3%  
Investments  -598 -594 -619 -1,571 -629  

Net sales trend  3.0 4.0 5.0 5.0 5.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  26.6% 27.9% 25.2% 23.5% 26.3%  
EBIT %  18.5% 20.4% 17.9% 9.0% 20.5%  
EBIT to gross profit (%)  39.1% 41.8% 38.2% 20.0% 43.6%  
Net Earnings %  16.5% 17.6% 15.5% 8.7% 18.2%  
Profit before depreciation and extraordinary items %  24.6% 25.0% 22.8% 23.2% 24.0%  
Pre tax profit less extraordinaries %  20.8% 21.6% 19.0% 10.2% 22.9%  
ROA %  7.9% 12.6% 12.4% 9.2% 23.1%  
ROI %  8.4% 13.9% 13.7% 10.4% 26.3%  
ROE %  7.2% 12.4% 12.6% 10.3% 24.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  81.3% 82.9% 75.5% 72.9% 74.9%  
Relative indebtedness %  21.4% 21.3% 26.2% 22.3% 23.2%  
Relative net indebtedness %  21.3% 21.0% 26.0% 21.5% 22.7%  
Net int. bear. debt to EBITDA, %  16.0% 12.4% 48.6% 31.1% 41.3%  
Gearing %  3.0% 2.5% 11.7% 11.3% 14.5%  
Net interest  0 0 0 0 0  
Financing costs %  2.1% 6.1% 3.4% 2.4% 3.3%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.2 4.1 2.6 2.0 2.6  
Current Ratio  3.4 4.2 2.7 2.3 2.8  
Cash and cash equivalent  3.7 16.1 9.1 44.4 26.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  12.2 13.0 15.1 8.4 13.6  
Trade creditors turnover (days)  181.1 144.0 117.4 140.2 127.8  
Current assets / Net sales %  72.9% 89.3% 69.9% 49.3% 63.1%  
Net working capital  2,243.5 3,197.4 2,228.4 1,516.3 2,261.5  
Net working capital %  51.6% 68.2% 44.2% 27.5% 40.5%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  4 4 4 5 5  
Added value / employee  1 1 1 1 1  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1 1 1 1 1  
EBIT / employee  1 1 1 0 1  
Net earnings / employee  1 1 1 0 1